European Study of Adjuvant Chemotherapies
in Resectable Pancreatic Cancer
(ESPAC) 3
Phase III adjuvant trial in pancreatic cancer comparing: 5-fluorouracil + D-L folinic acid with gemcitabine or no adjuvant treatment.
Schema
Summary
Surgery is the best treatment for cancers of the pancreas that have not spread further. However, despite the best surgery, the cancer often comes back (recurs). This trial will determine if chemotherapy given after surgery can prevent or delay cancer recurrence and its effects on quality of life.
